Evrard Anesthésiste SRL
Evrard Anesthésiste reported total assets of 147,314 € at the end of the 2024 financial year (annual accounts filed with the NBB on 28 Dec 2025).
The score of Evrard Anesthésiste shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +49 % Total assets +42 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Evrard Anesthésiste's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 28 Dec 2025
- Year ended 31 Dec 2023filed on 28 Dec 2025
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
- Year ended 31 Dec 2020filed on 23 Jun 2021
Evrard Anesthésiste's financial analysis
- Solvency91.9%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Evrard Anesthésiste
Evrard Anesthésiste's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0696.843.050
- VAT number
- BE0696843050
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 28 May 2018
- Registered office
- 5500 Dinant
- Latest accounts
- 2024 · filed on 28 Dec 2025
- Activity
- Medical specialists activities (NACE 86220)
Evrard Anesthésiste (SRL) has been based in Dinant since 2018, active in: medical specialists activities. For 2024, it reports a net profit of 5,844 € and equity of 135,319 €; its revenue is not published. Its solvency stands at 91.9%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Evrard Anesthésiste
Companies in the same business, of comparable size and area, outside its group.
- Chirurgie plastique Docteur Jean-Christophe GRUSLIN Medical specialists activities Couvin · balance sheet 147,046 €
- Dr. Maarten Rombauts Medical specialists activities Lier · balance sheet 146,643 €
- Dr. Francis Somville Medical specialists activities Lint · balance sheet 147,270 €
- Dr. Marta Malinowska, Chirurg Medical specialists activities Wezembeek-Oppem · balance sheet 147,237 €
- Dr. Lisa-Marie Langermans Medical specialists activities Schoten · balance sheet 147,422 €
- Docteur Maria Antoci Medical specialists activities Wavre · balance sheet 147,165 €
- Dr. Gwendolyne Peeters - anesthesie-reanimatie Medical specialists activities Merelbeke-Melle · balance sheet 147,076 €
- Cabinet de Psychiatrie du Dr Lognoul Medical specialists activities Visé · balance sheet 147,779 €
Frequently asked questions about Evrard Anesthésiste
What is the revenue of Evrard Anesthésiste?
Evrard Anesthésiste files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Evrard Anesthésiste?
In Belgium, the VAT number is the company number prefixed with BE: BE0696843050 for Evrard Anesthésiste, if the company is VAT-registered. Its company number (CBE) is 0696.843.050.
Where is the registered office of Evrard Anesthésiste?
According to the CBE register, the registered office of Evrard Anesthésiste is in 5500 Dinant.
What is the equity of Evrard Anesthésiste?
At the close of the 2024 financial year, the equity of Evrard Anesthésiste amounts to 135,319 €, a solvency of 91.9% of total assets.
Who manages Evrard Anesthésiste?
The register lists 1 active mandates at Evrard Anesthésiste. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Evrard Anesthésiste
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →